ERBB2 and cholangiocarcinoma: Furthermore, ERBB2 gene alterations are characteristic genetic abnormalities in CCA, with frequencies reported to be 4–6% in iCCA and 3–20% in eCCA, showing a tendency to be more common in eCCA [48,68,69,70,71,72].